These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35922950)

  • 1. [Treatment strategy for infant acute lymphoblastic leukemia].
    Miyamura T
    Rinsho Ketsueki; 2022; 63(7):791-798. PubMed ID: 35922950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infant acute lymphoblastic leukemia: treatment strategies and new insights].
    Miyamura T; Tomizawa D
    Rinsho Ketsueki; 2021; 62(11):1567-1575. PubMed ID: 34866078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment strategy for infants with acute lymphoblastic leukemia].
    Miyamura T
    Rinsho Ketsueki; 2019; 60(9):1317-1323. PubMed ID: 31597858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.
    Pieters R; De Lorenzo P; Ancliffe P; Aversa LA; Brethon B; Biondi A; Campbell M; Escherich G; Ferster A; Gardner RA; Kotecha RS; Lausen B; Li CK; Locatelli F; Attarbaschi A; Peters C; Rubnitz JE; Silverman LB; Stary J; Szczepanski T; Vora A; Schrappe M; Valsecchi MG
    J Clin Oncol; 2019 Sep; 37(25):2246-2256. PubMed ID: 31283407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.
    Chijimatsu I; Imanaka Y; Tomizawa D; Eguchi M; Nishimura S; Karakawa S; Miki M; Hamamoto K; Fujita N
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28675638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia.
    Blackburn PR; Smadbeck JB; Znoyko I; Webley MR; Pitel BA; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Lindsey KG; Schandl CA; Wolff DJ; Peterson JF
    Genes Chromosomes Cancer; 2020 Jul; 59(7):422-427. PubMed ID: 32196814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute lymphoblastic leukemia in infants: A quarter century of nationwide efforts in Japan.
    Tomizawa D; Miyamura T; Koh K; Ishii E
    Pediatr Int; 2022 Jan; 64(1):e14935. PubMed ID: 34324764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial.
    Fechina L; Popov A; Tsaur G; Henze G; Shorikov E; Makarova O; Khlebnikova O; Zhukova Y; Arakaev O; Streneva O; Verzhbitskaya T; Riger T; Solodovnikov A; Lapotentova E; Aleinikova O; Myakova N; Boichenko E; Kondratchik K; Nikonova O; Shapochnik A; Goroshkova M; Ponomareva N; Novichkova G; Karachunskiy A; Roumiantsev A
    Leukemia; 2023 Nov; 37(11):2276-2281. PubMed ID: 37741948
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
    Driessen EM; van Roon EH; Spijkers-Hagelstein JA; Schneider P; de Lorenzo P; Valsecchi MG; Pieters R; Stam RW
    Haematologica; 2013 Jun; 98(6):937-44. PubMed ID: 23403319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation for infants with high-risk KMT2A gene-rearranged acute lymphoblastic leukemia.
    Takachi T; Watanabe T; Miyamura T; Moriya Saito A; Deguchi T; Hori T; Yamada T; Ohmori S; Haba M; Aoki Y; Ishimaru S; Sasaki S; Ohshima J; Iguchi A; Takahashi Y; Hyakuna N; Manabe A; Horibe K; Ishii E; Koh K; Tomizawa D
    Blood Adv; 2021 Oct; 5(19):3891-3899. PubMed ID: 34500465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infant acute lymphoblastic leukemia: Lessons learned and future directions.
    Pieters R
    Curr Hematol Malig Rep; 2009 Jul; 4(3):167-74. PubMed ID: 20425430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial.
    Tomizawa D; Miyamura T; Imamura T; Watanabe T; Moriya Saito A; Ogawa A; Takahashi Y; Hirayama M; Taki T; Deguchi T; Hori T; Sanada M; Ohmori S; Haba M; Iguchi A; Arakawa Y; Koga Y; Manabe A; Horibe K; Ishii E; Koh K
    Blood; 2020 Oct; 136(16):1813-1823. PubMed ID: 32845001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group.
    Tomizawa D; Koh K; Hirayama M; Miyamura T; Hatanaka M; Saikawa Y; Ishii E
    Pediatr Blood Cancer; 2009 Jul; 52(7):808-13. PubMed ID: 19229974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution and optimization of therapies for acute lymphoblastic leukemia in infants.
    Tomizawa D
    Int J Hematol; 2023 Feb; 117(2):162-172. PubMed ID: 36441356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group.
    Tomizawa D; Koh K; Sato T; Kinukawa N; Morimoto A; Isoyama K; Kosaka Y; Oda T; Oda M; Hayashi Y; Eguchi M; Horibe K; Nakahata T; Mizutani S; Ishii E
    Leukemia; 2007 Nov; 21(11):2258-63. PubMed ID: 17690691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.
    Popov A; Tsaur G; Permikin Z; Henze G; Verzhbitskaya T; Plekhanova O; Nokhrina E; Valochnik A; Sibiryakov P; Zerkalenkova E; Olshanskaya Y; Gindina T; Movchan L; Shorikov E; Streneva O; Khlebnikova O; Makarova O; Arakaev O; Boichenko E; Kondratchik K; Ponomareva N; Lapotentova E; Aleinikova O; Miakova N; Novichkova G; Karachunskiy A; Fechina L
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30204. PubMed ID: 36715125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLL-Rearranged Acute Lymphoblastic Leukemia.
    El Chaer F; Keng M; Ballen KK
    Curr Hematol Malig Rep; 2020 Apr; 15(2):83-89. PubMed ID: 32350732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid lineage switch in
    Bataller A; Abuasab T; McCall D; Wang W; Cuglievan B; Issa GC; Jabbour E; Short N; DiNardo CD; Tang G; Garcia-Manero G; Kantarjian HM; Sasaki K
    Haematologica; 2024 Jan; 109(1):293-297. PubMed ID: 37646654
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in
    Fournier E; Inchiappa L; Delattre C; Pignon JM; Danicourt F; Bemba M; Roche-Lestienne C; Daudignon A; Decool G; Roumier C; Dumezy F; Fournier L; Grardel N; Preudhomme C; Duployez N
    Leuk Lymphoma; 2019 Jul; 60(7):1827-1830. PubMed ID: 30616415
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study.
    Mann G; Attarbaschi A; Schrappe M; De Lorenzo P; Peters C; Hann I; De Rossi G; Felice M; Lausen B; Leblanc T; Szczepanski T; Ferster A; Janka-Schaub G; Rubnitz J; Silverman LB; Stary J; Campbell M; Li CK; Suppiah R; Biondi A; Vora A; Valsecchi MG; Pieters R;
    Blood; 2010 Oct; 116(15):2644-50. PubMed ID: 20592248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.